232 related articles for article (PubMed ID: 33193994)
1. [Role and effectiveness of radioactive-iodine therapy for the treatment of Grave's disease].
Sellem A; Elajmi W; Mhamed RB; Oueslati N; Ouertani H; Hammami H
Pan Afr Med J; 2020; 36():341. PubMed ID: 33193994
[TBL] [Abstract][Full Text] [Related]
2. Radioactive iodine therapy in Graves' hyperthyroidism: a prospective study from a tertiary referral centre in north India.
Sankar R; Sekhri T; Sripathy G; Walia RP; Jain SK
J Assoc Physicians India; 2005 Jul; 53():603-6. PubMed ID: 16190128
[TBL] [Abstract][Full Text] [Related]
3. The Long-Term Outcome of Treatment for Graves' Hyperthyroidism.
Sjölin G; Holmberg M; Törring O; Byström K; Khamisi S; de Laval D; Abraham-Nordling M; Calissendorff J; Lantz M; Hallengren B; Filipsson Nyström H; Wallin G
Thyroid; 2019 Nov; 29(11):1545-1557. PubMed ID: 31482765
[No Abstract] [Full Text] [Related]
4. Impact of lithium on efficacy of radioactive iodine therapy for Graves' disease: a cohort study on cure rate, time to cure, and frequency of increased serum thyroxine after antithyroid drug withdrawal.
Bogazzi F; Giovannetti C; Fessehatsion R; Tanda ML; Campomori A; Compri E; Rossi G; Ceccarelli C; Vitti P; Pinchera A; Bartalena L; Martino E
J Clin Endocrinol Metab; 2010 Jan; 95(1):201-8. PubMed ID: 19906789
[TBL] [Abstract][Full Text] [Related]
5. High dose of (131)I therapy for the treatment of hyperthyroidism caused by Graves' disease.
Alexander EK; Larsen PR
J Clin Endocrinol Metab; 2002 Mar; 87(3):1073-7. PubMed ID: 11889166
[TBL] [Abstract][Full Text] [Related]
6. Graves' disease in children.
Léger J; Oliver I; Rodrigue D; Lambert AS; Coutant R
Ann Endocrinol (Paris); 2018 Dec; 79(6):647-655. PubMed ID: 30180972
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology, management and outcomes of Graves' disease-real life data.
Hussain YS; Hookham JC; Allahabadia A; Balasubramanian SP
Endocrine; 2017 Jun; 56(3):568-578. PubMed ID: 28478488
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of single-session radiofrequency ablation (RFA) in rendering euthyroidism for persistent/relapsed Graves' disease, a pilot study.
Fung MHM; Lang BHH
Eur Radiol; 2023 Sep; 33(9):6534-6544. PubMed ID: 37036479
[TBL] [Abstract][Full Text] [Related]
9. The effect of propylthiouracil on subsequent radioactive iodine therapy in Graves' disease.
Hancock LD; Tuttle RM; LeMar H; Bauman J; Patience T
Clin Endocrinol (Oxf); 1997 Oct; 47(4):425-30. PubMed ID: 9404440
[TBL] [Abstract][Full Text] [Related]
10. Radioactive iodine ablation therapy: a viable option in the management of Graves' disease in Nigeria.
Adedapo KS; Fadiji IO; Orunmuyi AT; Onimode Y; Osifo BO
Afr J Med Med Sci; 2012 Dec; 41 Suppl():193-6. PubMed ID: 23678656
[TBL] [Abstract][Full Text] [Related]
11. Prospective study to evaluate radioactive iodine of 20 mCi vs 10-15 mCi in Graves' disease.
Kanokwongnuwat W; Penpong N
BMC Endocr Disord; 2024 Apr; 24(1):54. PubMed ID: 38664774
[TBL] [Abstract][Full Text] [Related]
12. Predictors of Prolonged Euthyroidism After Radioactive Iodine Treatment for Graves' Disease: A Pilot Study.
Lu JY; Chen KH; Shih SR; Wen FY; Wu WC; Chen TC; Hu FC
Endocr Pract; 2023 Feb; 29(2):89-96. PubMed ID: 36396015
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant lithium improves the efficacy of radioactive iodine treatment in Graves' and toxic nodular disease.
Martin NM; Patel M; Nijher GM; Misra S; Murphy E; Meeran K
Clin Endocrinol (Oxf); 2012 Oct; 77(4):621-7. PubMed ID: 22443227
[TBL] [Abstract][Full Text] [Related]
14. The characteristics of Grave's disease in children and adolescent patients in Al-Madinah Al-Munawwarah: A retrospective chart review.
Alradadi RS; Omar NA; Alhusayni RA; Almokhtar AM; Muhawish SF; Altaleb MM; Tawfiq SA; Alraddadi RM; Almalki RQ
Saudi Med J; 2023 Mar; 44(3):284-288. PubMed ID: 36940965
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of long-term follow-up and methimazole therapy outcomes of pediatric Graves' disease: a single-center experience.
Bayramoğlu E; Elmaogulları S; Sagsak E; Aycan Z
J Pediatr Endocrinol Metab; 2019 Apr; 32(4):341-346. PubMed ID: 30862763
[TBL] [Abstract][Full Text] [Related]
16. Long-term follow-up study of radioiodine treatment of hyperthyroidism.
Metso S; Jaatinen P; Huhtala H; Luukkaala T; Oksala H; Salmi J
Clin Endocrinol (Oxf); 2004 Nov; 61(5):641-8. PubMed ID: 15521969
[TBL] [Abstract][Full Text] [Related]
17. Graves' Disease: Can It Be Cured?
Wiersinga WM
Endocrinol Metab (Seoul); 2019 Mar; 34(1):29-38. PubMed ID: 30912336
[TBL] [Abstract][Full Text] [Related]
18. Evidence for higher success rates and successful treatment earlier in Graves' disease with higher radioactive iodine doses.
Sztal-Mazer S; Nakatani VY; Bortolini LG; Boguszewski CL; Graf H; de Carvalho GA
Thyroid; 2012 Oct; 22(10):991-5. PubMed ID: 22953990
[TBL] [Abstract][Full Text] [Related]
19. Graves' disease in Saudi Arabia: a ten-year hospital study.
Malabu UH; Alfadda A; Sulimani RA; Al-Rubeaan KA; Al-Ruhaily AD; Fouda MA; Al-Maatouq MA; El-Desouki MI
J Pak Med Assoc; 2008 Jun; 58(6):302-4. PubMed ID: 18988387
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcome of patients treated with antithyroid drugs, radioactive iodine or surgery for persistent or relapsed Graves' disease.
Liu X; Wong CKH; Chan WWL; Tang EHM; Woo YC; Liu SYW; Lam CLK; Lang BHH
Br J Surg; 2022 Mar; 109(4):381-389. PubMed ID: 35136950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
